Ziprax 50mg Dry Syrup contains Cefixime 50mg, a third-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. It is indicated for the treatment of respiratory tract infections, urinary tract infections, otitis media, pharyngitis, and uncomplicated gonorrhea caused by susceptible strains of bacteria. Cefixime acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Ziprax 50mg Dry Syrup is formulated for oral administration, making it suitable for pediatric and adult patients who have difficulty swallowing tablets. The dry syrup should be reconstituted with the appropriate amount of water before use, ensuring accurate dosing and improved palatability. It is important to complete the full prescribed course to prevent the development of antibiotic resistance. Common side effects may include gastrointestinal disturbances such as diarrhea, nausea, abdominal pain, and hypersensitivity reactions like rash or pruritus. Caution is advised in patients with a history of penicillin or cephalosporin allergy. Dose adjustments may be necessary in patients with renal impairment. Ziprax 50mg Dry Syrup should be stored in a cool, dry place away from direct sunlight and out of reach of children. Always consult a healthcare professional before initiating therapy.